Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Quadrivalent human papillomavirus

The quadrivalent human papillomavirus vaccine is recommended as a three-dose series (0, 2, and 6 months) for all females 11 to 12 years old. The vaccine is licensed for females 9 to 26 years of age. [Pg.583]

Slade BA, Leidel L, Vellozzi C, Woo EJ, Hua W, Sutherland A, Izurieta HS, Ball R, Miller N, Braun MM, Markowitz LE, Iskander J. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA 2009 302 750-7. [Pg.666]

Mok CC, Ho LY, Fong LS, To CH. Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus a case-conbol study. Ann Rheum Dis 2013 72(5) 659-64. [Pg.479]

Siddiqui MA, Perry CM (2006) Human papillomavirus quadrivalent (types 6, 11, 16, 18) recombinant vaccine (Gardasil). Drugs 66 1263-1271... [Pg.48]

See other pages where Quadrivalent human papillomavirus is mentioned: [Pg.269]    [Pg.269]    [Pg.269]    [Pg.269]    [Pg.269]    [Pg.269]   


SEARCH



Human papillomavirus

Human papillomaviruses

Papillomavirus

© 2024 chempedia.info